<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A number of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> possess constitutive activity of the dsRNA-dependent kinase, PKR </plain></SENT>
<SENT sid="1" pm="."><plain>Inhibition of PKR in these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> leads to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We recently reported the increased presence of PKR phosphorylated on Thr451 (p-T451 PKR) in clinical samples from <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) patients and <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>Whereas p-T451 PKR in low-risk patient samples or PTEN-positive <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> cell lines was mostly cytoplasmic, in high-risk patient samples and <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> cell lines deficient in PTEN, p-T451 PKR was mainly nuclear </plain></SENT>
<SENT sid="4" pm="."><plain>As nuclear activity of PKR has not been previously characterized, we examined the status of nuclear PKR in <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>Using antibodies to N-terminus, C-terminus and the kinase domain in conjunction with a proteomics approach, we found that PKR exists in diverse molecular weight forms in the nucleus </plain></SENT>
<SENT sid="6" pm="."><plain>Analysis of PKR transcripts by reverse transcriptase-PCR, and PKR-derived <z:chebi fb="7" ids="16670">peptides</z:chebi> by MS/MS revealed that these forms were the result of post-translational modifications (PTMs) </plain></SENT>
<SENT sid="7" pm="."><plain>Biochemical analysis demonstrated that nuclear PKR is an active kinase that can respond to stress </plain></SENT>
<SENT sid="8" pm="."><plain>Given the association of PKR with PTEN and the Fanconi complex, these results indicate that PKR likely has other previously unrecognized roles in nuclear signaling that may contribute to leukemic development </plain></SENT>
</text></document>